Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Björklund

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Parkinson'S Disease|December 26, 2018
Repairing the Brain: Gene TherapyTomas Björklund
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2015
Expression of Multiple Functional RNAs or Proteins from One Viral VectorTomas Björklund
Journal of Parkinson'S Disease|August 9, 2021
Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral VectorsTomas Björklund, Marcus Davidsson
Biochimica Et Biophysica Acta|March 4, 2009
Scientific rationale for the development of gene therapy strategies for Parkinson's diseaseTomas Björklund, Deniz Kirik
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2019
Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian BrainPatrick Aldrin-Kirk, Tomas Björklund
Science Translational Medicine|April 7, 2010
Gene therapy for dopamine replacement in Parkinson's diseaseAnders Björklund, Tomas Björklund, Deniz Kirik
Current Opinion in Genetics & Development|June 27, 2021
In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?Malin Parmar, Anders Björklund, Tomas Björklund
Current Gene Therapy|April 14, 2007
Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategyThomas Carlsson, Tomas Björklund, Deniz Kirik
Progress in Brain Research|October 5, 2010
Gene therapy for dopamine replacementTomas Björklund, Erik Ahlm Cederfjäll, Deniz Kirik
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2012
Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's diseaseErik Cederfjäll, Gurdal Sahin, Deniz Kirik, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Parkinson'S Disease|December 26, 2018
Repairing the Brain: Gene TherapyTomas Björklund
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2015
Expression of Multiple Functional RNAs or Proteins from One Viral VectorTomas Björklund
Journal of Parkinson'S Disease|August 9, 2021
Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral VectorsTomas Björklund, Marcus Davidsson
Biochimica Et Biophysica Acta|March 4, 2009
Scientific rationale for the development of gene therapy strategies for Parkinson's diseaseTomas Björklund, Deniz Kirik
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2019
Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian BrainPatrick Aldrin-Kirk, Tomas Björklund
Science Translational Medicine|April 7, 2010
Gene therapy for dopamine replacement in Parkinson's diseaseAnders Björklund, Tomas Björklund, Deniz Kirik
Current Opinion in Genetics & Development|June 27, 2021
In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?Malin Parmar, Anders Björklund, Tomas Björklund
Current Gene Therapy|April 14, 2007
Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategyThomas Carlsson, Tomas Björklund, Deniz Kirik
Progress in Brain Research|October 5, 2010
Gene therapy for dopamine replacementTomas Björklund, Erik Ahlm Cederfjäll, Deniz Kirik
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2012
Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's diseaseErik Cederfjäll, Gurdal Sahin, Deniz Kirik, et al.
Pageof 5